| Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis. | |
| | |
MedLine Citation:
|
PMID: 9829886 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Following renal artery angioplasty and stenting, a female hypertensive patient suffered left renal artery stent subacute thrombosis. A second successful angioplasty was performed using 5000 U heparin i.v. and 0.25-mg/kg bolus followed by a 12-hr 10-microg/min infusion of abciximab. Normal renal flow was re-established and remained normal at 1-year follow-up. |
| | |
Authors:
|
D C Berkompas |
Related Documents
:
|
1476966 - Renovascular hypertension in a newborn: necessity of assessing blood pressure routinely. 446496 - Renal arterial thrombosis after the contralateral removal of a pelvic kidney. 11522876 - Helical ct angiography in evaluation of live kidney donors. 3051136 - Additional extrarenal abnormalities seen in tc-99m dtpa renal flow study. 12901816 - Unusual complication of ingestion of a foreign body. 8768776 - Congenitally absent pulmonary veins--diagnostic pitfalls. two case reports. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Catheterization and cardiovascular diagnosis Volume: 45 ISSN: 0098-6569 ISO Abbreviation: Cathet Cardiovasc Diagn Publication Date: 1998 Nov |
Date Detail:
|
Created Date: 1999-01-20 Completed Date: 1999-01-20 Revised Date: 2013-05-24 |
Medline Journal Info:
|
Nlm Unique ID: 7508512 Medline TA: Cathet Cardiovasc Diagn Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 272-4 Citation Subset: IM |
Affiliation:
|
Thoracic and Cardiovascular Institute, Lansing, Michigan 48910, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty*
/
adverse effects Antibodies, Monoclonal / administration & dosage, therapeutic use* Anticoagulants / administration & dosage, therapeutic use Blood Flow Velocity Female Follow-Up Studies Graft Occlusion, Vascular / diagnosis, physiopathology, therapy* Heparin / administration & dosage, therapeutic use Humans Immunoglobulin Fab Fragments / administration & dosage, therapeutic use* Infusions, Intravenous Middle Aged Platelet Aggregation Inhibitors / administration & dosage, therapeutic use* Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors Prosthesis Failure Renal Artery / radiography, ultrasonography Renal Artery Obstruction / diagnosis, physiopathology, therapy* Reoperation Stents |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Anticoagulants; 0/Immunoglobulin Fab Fragments; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 9005-49-6/Heparin; X85G7936GV/abciximab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Transcatheter closure of an anomalous venous connection by a novel method.
Next Document: Primary stent implantation for acute myocardial infarction during pregnancy: use of abciximab, ticlo...